Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities

LONG BEACH, Calif. and TORONTO, July 27, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that the Company has retained Matt Murphy, as an advisor on DEA compliance as it relates to instituting regulations related to interstate commerce and the export of medical cannabis compliant with Schedule III regulatory requirements contained in the Controlled Substances Act (CSA).

Mr. Murphy is the Founder and President of Pharma Compliance Group (“PCG”), an advisory firm specializing in providing compliance expertise to pharmaceutical companies assisting them to comply with the regulations related to the Controlled Substances Act (“CSA”) and the Code of Federal Regulations (“CFR”), enforced by the DEA, as it pertains to pharmaceutical drug manufacturing, wholesale drug distribution and retail pharmacy operations. Prior to founding PCG, Mr. Murphy had a distinguished twenty-six-year career with the Drug Enforcement Administration (“DEA”) as a Special Agent and regulatory subject matter expert. Mr. Murphy served as the Chief of Pharmaceutical Investigations for the DEA and retired as the Assistant Special Agent in Charge in the New England Field Division.